Eastern Cooperative Oncology Group
- Country
- ๐บ๐ธUnited States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
- Conditions
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 167
- Registration Number
- NCT00003444
- Locations
- ๐บ๐ธ
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
๐บ๐ธCCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
๐บ๐ธCCOP - Northern New Jersey, Hackensack, New Jersey, United States
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 36
- Registration Number
- NCT00082797
- Locations
- ๐บ๐ธ
Galesburg Cottage Hospital, Galesburg, Illinois, United States
๐บ๐ธRush-Copley Cancer Care Center, Aurora, Illinois, United States
๐บ๐ธHubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States
Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
- Conditions
- First Posted Date
- 2004-05-12
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 36
- Registration Number
- NCT00002826
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
๐บ๐ธKimball Medical Center, Lakewood, New Jersey, United States
๐บ๐ธSt. Francis Medical Center, Trenton, New Jersey, United States
Combination Chemotherapy in Treating Patients With Bladder Cancer
- Conditions
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 490
- Registration Number
- NCT00003701
- Locations
- ๐บ๐ธ
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
๐บ๐ธNYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
๐บ๐ธCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
- Conditions
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00003017
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
๐บ๐ธUniversity of Rochester Cancer Center, Rochester, New York, United States
๐บ๐ธVanderbilt Cancer Center, Nashville, Tennessee, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed
- Conditions
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 294
- Registration Number
- NCT00003235
- Locations
- ๐บ๐ธ
St. Francis Medical Center, Trenton, New Jersey, United States
๐บ๐ธTrinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey, United States
๐บ๐ธCommunity Medical Center, Toms River, New Jersey, United States
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Conditions
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00003809
- Locations
- ๐บ๐ธ
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
๐บ๐ธSylvester Cancer Center, University of Miami, Miami, Florida, United States
๐บ๐ธVeterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
- Conditions
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 38
- Registration Number
- NCT00003283
- Locations
- ๐บ๐ธ
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
๐บ๐ธCCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
๐บ๐ธIreland Cancer Center, Cleveland, Ohio, United States
Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy
- Conditions
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 334
- Registration Number
- NCT00003010
- Locations
- ๐บ๐ธ
CCOP - Carle Cancer Center, Urbana, Illinois, United States
๐บ๐ธSiouxland Hematology-Oncology, Sioux City, Iowa, United States
๐บ๐ธCCOP - Duluth, Duluth, Minnesota, United States
Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2004-04-12
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00004860
- Locations
- ๐บ๐ธ
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
๐บ๐ธJohns Hopkins Oncology Center, Baltimore, Maryland, United States
๐บ๐ธFox Chase Cancer Center, Philadelphia, Pennsylvania, United States